CareDx, Inc. (CDNA) News

CareDx, Inc. (CDNA)

Today's Latest Price: $50.18 USD

0.00 (0.00%)

Updated Oct 26 8:01am

Add CDNA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

Filter CDNA News Items

CDNA News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest CDNA News From Around the Web

Below are the latest news stories about CareDx Inc that investors may wish to consider to help them evaluate CDNA as an investment opportunity.

The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Annexon Inc (NASDAQ: ANNX ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) CareDx Inc (NASDAQ: CDNA ) CTI BioPharma Corp (NASDAQ: CTIC ) I-Mab ADR (NASDAQ: IMAB ) Insulet Corporation (NASDAQ: PODD ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kura Oncology Inc (NASDAQ: KURA ) LifeSci Acquisition Corp (NASDAQ: LSAC ) (the blank check company announced a business combination with oncology-focused Vincera Pharma) Mirati Th...

Benzinga | October 1, 2020

Transplant Diagnostics Market With Current Trends Analysis 2020: Omixon Ltd., CareDx, Affymetrix, Inc, Abbott Laboratories, Inc, Thermo Fisher Scientific, Inc

The Business Research Company offers " Transplant Diagnostics Global Market Report 2020-30: Covid 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective

OpenPR | September 29, 2020

CareDx EPS beats by $0.08, beats on revenue

CareDx (CDNA): Q2 Non-GAAP EPS of $0.04 beats by $0.08; GAAP EPS of -$0.15 in-line.Revenue of $41.8M (+32.9% Y/Y) beats by $6.19M.Press Release...

Seeking Alpha | August 4, 2020

CareDx to Participate at the Canaccord Genuity 40th Annual Growth Conference

SOUTH SAN FRANCISCO, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announces today it will be participating in the Canaccord Genuity 40th Annual Growth Conference, scheduled to be held virtually August 11-13, 2020. CareDx’s management is scheduled to present on Wednesday, August 12, 2020, at 1:00 p.m. EDT. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at investors.caredxinc.com. About CareDx CareDx, Inc., headquartered in South San Francisco, California, is a leading precision me...

Yahoo | July 30, 2020

3 Artificial Intelligence Stocks With Long-Term Narratives

Artificial intelligence (AI) is a buzzword in tech these days. The term, which encompasses a range of technologies including machine learning and data analysis. The goal is to create systems that can perceive, learn, and reason in ways that mimic human capabilities. At its best, AI will allow machines to understand the gestalt of a situation and react accordingly, a capability that humans take for granted – but has tended to elude computer systems, which in their turn excel at analyzing minute details.A wide range of tech companies are working on AI systems; artificial intelligence holds the promise of real-time data analysis and situation monitoring, with the machines capable of handling routine decisions. While it hasn’t been achieved yet, the outlines of success are visible on the ho...

Yahoo | July 25, 2020

CareDx to Report Second Quarter 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., July 16, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.

Yahoo | July 16, 2020

CareDx Chairman and CEO Peter Maag to Present at Global Kidney Innovations Summit

SOUTH SAN FRANCISCO, Calif., July 15, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.

Yahoo | July 15, 2020

Edited Transcript of CDNA earnings conference call or presentation 30-Apr-20 8:30pm GMT

Q1 2020 CareDx Inc Earnings Call

Yahoo | June 29, 2020

Hedge Funds Aren’t Crazy About CareDx, Inc. (CDNA) Anymore

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary

Yahoo Finance | June 24, 2020

New Kidney360 Publication Highlights CareDx’s AlloSure is Differentiated as the dd-cfDNA Test of Choice

SOUTH SAN FRANCISCO, Calif., June 22, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.

Yahoo | June 22, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5737 seconds.